PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $318,884,000 | +126.6% | 13,822,463 | 0.0% | 2.79% | +57.7% |
| Q3 2020 | $140,713,000 | -31.7% | 13,822,463 | 0.0% | 1.77% | -39.0% |
| Q2 2020 | $205,955,000 | +22.2% | 13,822,463 | 0.0% | 2.90% | +2.4% |
| Q1 2020 | $168,496,000 | -23.0% | 13,822,463 | 0.0% | 2.83% | -9.3% |
| Q4 2019 | $218,810,000 | +28.9% | 13,822,463 | 0.0% | 3.12% | -3.0% |
| Q3 2019 | $169,740,000 | -7.0% | 13,822,463 | 0.0% | 3.22% | +14.0% |
| Q2 2019 | $182,457,000 | – | 13,822,463 | – | 2.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|